ENTYVIO (vedolizumab)

ENTYVIO (vedolizumab) for injection

Vedolizumab, an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody produced in Chinese hamster ovary cells. ENTYVIO is indicated in adults for the treatment of moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease